CORRESPONDENCE
Figure 1 | curatedMetagenomicData production pipeline and examples of enabled analyses. The pipeline (left) processes raw metagenomic sequence data to produce taxonomic and functional profiles, integrates these with curated sample data, then documents and packages these for distribution through ExperimentHub as the curatedMetagenomicData package. Example 1: health status was classified for six data sets, five data types each, using a random-forest algorithm and cross-validation to estimate prediction accuracy. Example 2: unsupervised clustering of human gut samples (n = 3,667) using the Bray-Curtis metric and partitioning around medoids. In Cluster 1, Bacteroides relative abundance is shown by point borders and Prevotella copri by centers. Example 3: abundance at the phylum level in human gut samples. Example 4: correlation between Prevotella copri and inosine 5 phosphate biosynthesis, the most correlated species-pathway pair (see Supplementary Fig. 4 for heatmap of most highly correlated species-pathway pairs). These analyses were performed using the script provided in the vignettes/extras package directory. bial communities are strongly patterned by a continuous gradient between relative abundance of Prevotella copri and Bacteroides spp (Fig. 1 , example 2) with little or no support for any discrete clusters (Supplementary Fig. 1 ). This is consistent with the analysis of Koren et al. 5 but stands in contrast with the three-enterotypes hypothesis of Arumugam et al. 6 . Third, we visualized the continuum of the firmicutes-bacteroidetes gradient in gut microbiomes (Fig. 1, example  3 ). This continuum has been previously reported 4 , but not for thousands of microbial species on thousands of individuals as analyzed here. Finally, we ranked all taxa-pathway pairs by magnitude of correlation in samples. The highest correlation pair shown demonstrates a strong relationship between Prevotella copri abundance and inosine 5 phosphate biosynthesis ( Fig. 1 , example 4), and this suggests functional differences along the gradient shown in example 2. These and other analyses (Supplementary Figs. 1-5) would be very large undertakings using less curated databases such as IMG/M or EBI Metagenomics; but they are straightforward, documented, and reproducible using curatedMetagenomicData. Our large-scale, curated integration of metagenomic data is well documented and readily usable by broad scientific communities for efficient hypothesis testing and methods development. The automated pipeline allows the resource to be continually expanded by the team and community contributors (Supplementary Methods, package maintenance). By allowing researchers to bring their expertise to the analysis of metagenomic data without the need for extensive bioinformatic experience, curatedMetagenomicData greatly expands the accessibility of public data for study of the human microbiome.
Data availability statement. The curatedMetagenomicData data package is available online at https://waldronlab.github.io/curatedMetagenomicData/ and through the Bioconductor package installer.
A Life Sciences Reporting Summary is available. 
The Experimental Design Assistant
To the Editor: The quality and reliability of much animal research is in question. Unreliable or low-quality research represents an unacceptable waste of animals and research resources. In the US alone, the cost of irreproducible research has been estimated at $28 billion annually, and issues with research design and reporting are estimated to account for half of that waste 1 . To address these issues, the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) developed the ARRIVE guidelines to improve the reporting of in vivo research 2, 3 . We now present the Experimental Design Assistant (EDA; https://eda.nc3rs.org. uk), a freely accessible web-based tool, which was launched to help researchers improve the design, conduct, analysis and reporting of animal experiments.
The system was developed by progressive interaction between an expert group experienced in providing advice on experimental design to researchers and a software development team. It includes a computer-aided design tool through which the user develops a diagram that embodies the experimental plan. The diagram offers a new standard notation for describing experiments in which methodological details and analysis plans are explicit (Fig. 1) . This facilitates communication between collaborators, funding bodies, ethical review committees, journal editors and peer reviewers; it also allows detailed record keeping and may serve as an ex ante registered protocol 4 .
The structure of EDA diagrams is based on a series of relationships between the different components of the experiment. This allows the use of computer-based logical reasoning to provide feedback and advice on the experimental plans 5 . The feedback helps researchers improve their experimental design by, for instance, highlighting missing information or problems with internal consistency. It also provides assistance with identifying and characterizing the independent variables and outcome measures to be included in the analysis. Advice about common nuisance variables, which threaten the internal validity of many animal experiments, is also provided, along with practical suggestions to account for such variables in randomization and data analysis. The feedback does not restrict researchers to using a particular design type, but it promotes a better understanding of the implications of common design pitfalls so that researchers can make informed decisions. The feedback also suggests methods of statistical analysis that are appropriate for a given design, along with advice on any data requirements ('assumptions') for a given test as well as possible data transformations.
Other features of the EDA include support for randomization, blinding and power calculations, and procedures which are still underused in animal research 6 . Based on the diagram, the system generates a randomization sequence for the study, taking into 1 nature research | life sciences reporting summary Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design 1. Sample size
Describe how sample size was determined. curatedMetagenomicData is a database of human microbiome profiles from whole-metagenome shotgun sequencing from the Human Microbiome Project and as many other specimens collected from stool specimens as we have been able to find, curate, and process. Statistical parameters are not applicable for the database.
Data exclusions
Describe any data exclusions. N/A
Replication
Describe whether the experimental findings were reliably reproduced.
All findings reported in the paper are reproducible using the script we provide at https://github.com/waldronlab/curatedMetagenomicData/blob/master/vignettes/ extras/PaperFigures.Rmd
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
N/A
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
N/A
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Describe the software used to analyze the data in this study.
The offline pipeline for processing raw metagenomic data used publicly available MetaPhlAn2 and HUMAnN2 software. Code for all steps of downloading, proccessing, and generating the curatedMetagenomic package is available at www.github.com/waldronlab/curatedMetagenomicData, and the curatedMetagenomicData database is available through www.bioconductor.org.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species). This study involves only use of publicly available data and does not qualify as Human Subject Research.
